MAM
JW Marriott awards creative mandate to Everest Brand Solutions
MUMBAI: Everest Brand Solutions is the new creative partner of luxury hotel JW Marriott.
The creative duties will be handled by the agency‘s Mumbai office. The account was earlier handled by Onads Communications.
Confirming the news to indiantelevision.com, Everest Brand Solutions president Dhunji S Wadia said, “The account has been awarded to us and the media spends are in the range of Rs 70 to 80 million.”
The agency will be responsible for the corporate duties for the brand across India, starting from Mumbai. It will also be involved with the creative duties for Marriott‘s restaurants as well as events organised by the brand.
JW Marriott belongs to the parent company, Marriott International. The chain is a well-known brand across the globe and has hotels at places such as Shanghai, Phuket, London, Dubai, Cairo, Beijing, Kuala Lumpur and Bangkok.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
